In the last trading session, 2.74 million Nyxoah SA (NASDAQ:NYXH) shares changed hands as the company’s beta touched 1.62. With the company’s per share price at $6.06 changed hands at $0.35 or 6.13% during last session, the market valuation stood at $208.40M. NYXH’s last price was a discount, traded about -111.06% off its 52-week high of $12.79. The share price had its 52-week low at $5.55, which suggests the last value was 8.42% up since then. When we look at Nyxoah SA’s average trading volume, we note the 10-day average is 0.41 million shares, with the 3-month average coming to 60.17K.
Analysts gave the Nyxoah SA (NYXH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.44. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NYXH as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Nyxoah SA’s EPS for the current quarter is expected to be -0.5.
Nyxoah SA (NASDAQ:NYXH) trade information
Instantly NYXH was in green as seen at the end of in last trading. With action -11.79%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -24.25%, with the 5-day performance at -11.79% in the red. However, in the 30-day time frame, Nyxoah SA (NASDAQ:NYXH) is -37.07% down. Looking at the short shares, we see there were 63669.0 shares sold at short interest cover period of 1.82 days.
The consensus price target for the stock as assigned by Wall Street analysts is 17, meaning bulls need an upside of 64.35% from its current market value. According to analyst projections, NYXH’s forecast low is 17 with 17 as the target high. To hit the forecast high, the stock’s price needs a -180.53% plunge from its current level, while the stock would need to soar -180.53% for it to hit the projected low.
Nyxoah SA (NYXH) estimates and forecasts
Year-over-year growth is forecast to reach 322.18% up from the last financial year.
Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 1.64M. 7 analysts are of the opinion that Nyxoah SA’s revenue for the current quarter will be 2.58M. The company’s revenue for the corresponding quarters a year ago was 1.22M and 771k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 33.98%. The estimates for the next quarter sales put growth at 235.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -34.68%. The 2025 estimates are for Nyxoah SA earnings to decrease by -8.79%, but the outlook for the next 5-year period is at 17.55% per year.
NYXH Dividends
Nyxoah SA is expected to release its next quarterly earnings report on 2025-Mar-12.
Nyxoah SA (NASDAQ:NYXH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 38.32% of Nyxoah SA shares while 32.98% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 53.47%.
Among Mutual Funds, the top two as of Jan 31, 2025 were Fidelity Securities Fund-Fidelity Small Cap Growth Fund and BlackRock Health Sciences Term Trust . With 667.56 shares estimated at $4.05 million under it, the former controlled 1.78% of total outstanding shares. On the other hand, BlackRock Health Sciences Term Trust held about 1.73% of the shares, roughly 648.04 shares worth around $3.93 million.
